RxDoctor Payments Data

Harry Schneider, DPM

Foot & Ankle Surgery · Cambridge, MANPI 1245342914

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $130,313 of the $174,122 with a category attached, or 74.8%. Smith+Nephew accounts for 97.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $46,972 and has fallen 89.4% since, to $4,971 in 2025. Among foot & ankle surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$174,122in general payments, 2019–2025

Across 326 payments — averaging $534.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$169K
  • Kairos Surgical Inc$1K
  • Medline Industries LP$1K
  • Integra Lifesciences Corporation$732
  • Osiris Therapeutics Inc.$470
  • Stryker$244
  • plus $856 from 18 others

What the payments were for

  • Consulting fees$12,8347%
  • Speaking & faculty fees$130,31375%
  • Travel & lodging$22,89513%
  • Food & beverage$6,5464%
  • Education$1,2001%
  • Other$3330%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$174,122 in reported general payments places this provider in the 95th percentile of 122 foot & ankle surgery providers in Massachusetts.

See all foot & ankle surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$49,223
Medicare patients
209
Services billed
644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin91$1,033
Ammonium Lactate24$650
Diclofenac Sodium24$529
Terbinafine Hcl23$404
Pregabalin17$132
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$93

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Cambridge

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →